GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » Market Cap

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Market Cap : ¥4,655 Mil (As of May. 23, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Harbin Gloria Pharmaceuticals Co's share price for the quarter that ended in Mar. 2024 was ¥2.14. Harbin Gloria Pharmaceuticals Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 2,271 Mil. Therefore, Harbin Gloria Pharmaceuticals Co's market cap for the quarter that ended in Mar. 2024 was ¥4,859 Mil.

Harbin Gloria Pharmaceuticals Co's quarterly market cap increased from Sep. 2023 (¥4,968 Mil) to Dec. 2023 (¥5,517 Mil) but then declined from Dec. 2023 (¥5,517 Mil) to Mar. 2024 (¥4,859 Mil).

Harbin Gloria Pharmaceuticals Co's annual market cap declined from Dec. 2021 (¥6,397 Mil) to Dec. 2022 (¥5,583 Mil) and declined from Dec. 2022 (¥5,583 Mil) to Dec. 2023 (¥5,517 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Harbin Gloria Pharmaceuticals Co's Enterprise Value for Today is ¥4,356 Mil.


Harbin Gloria Pharmaceuticals Co Market Cap Historical Data

The historical data trend for Harbin Gloria Pharmaceuticals Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harbin Gloria Pharmaceuticals Co Market Cap Chart

Harbin Gloria Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,660.30 7,033.98 6,396.53 5,583.22 5,517.28

Harbin Gloria Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,275.49 4,703.98 4,967.75 5,517.28 4,858.89

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Harbin Gloria Pharmaceuticals Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's Market Cap falls into.



Harbin Gloria Pharmaceuticals Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Harbin Gloria Pharmaceuticals Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥2.51*2198.12
=¥5,517

Harbin Gloria Pharmaceuticals Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥2.14*2270.51
=¥4,859

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Harbin Gloria Pharmaceuticals Co  (SZSE:002437) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Harbin Gloria Pharmaceuticals Co Market Cap Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Traded in Other Exchanges
N/A
Address
Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines